The global drug formulation market is projected to grow significantly from USD 1.8 trillion in 2026 to USD 3.1 trillion by 2036, with a compound annual growth rate (CAGR) of 5.7%. Oral formulations are expected to dominate, capturing a 43.2% market share, while large pharmaceutical companies will account for 50% of end-user revenue. Growth drivers include an increasing focus on chronic disease treatments, advancements in drug delivery technologies, and demand for biologics and targeted therapies. Geographically, India is predicted to see the fastest growth at 6.5%, followed by China at 6.2%. Key players in the market are focusing on innovations and regulatory compliance to maintain competitive advantages.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.futuremarketinsights.com/reports/drug-formulation-market
